BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 16822902)

  • 21. [Analysis of gene expression and DNA methylation patterns in childhood acute lymphoblastic leukemia].
    Iijima K; Kiyokawa N
    Rinsho Ketsueki; 2016 Apr; 57(4):425-9. PubMed ID: 27169445
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Early relapse in ALL is identified by time to leukemia in NOD/SCID mice and is characterized by a gene signature involving survival pathways.
    Meyer LH; Eckhoff SM; Queudeville M; Kraus JM; Giordan M; Stursberg J; Zangrando A; Vendramini E; Möricke A; Zimmermann M; Schrauder A; Lahr G; Holzmann K; Schrappe M; Basso G; Stahnke K; Kestler HA; Te Kronnie G; Debatin KM
    Cancer Cell; 2011 Feb; 19(2):206-17. PubMed ID: 21295523
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Therapeutic strategies for childhood high-risk acute lymphoblastic leukemia].
    Lu XT
    Beijing Da Xue Xue Bao Yi Xue Ban; 2013 Apr; 45(2):327-32. PubMed ID: 23591360
    [TBL] [Abstract][Full Text] [Related]  

  • 24. ETV6/RUNX1-positive relapses evolve from an ancestral clone and frequently acquire deletions of genes implicated in glucocorticoid signaling.
    Kuster L; Grausenburger R; Fuka G; Kaindl U; Krapf G; Inthal A; Mann G; Kauer M; Rainer J; Kofler R; Hall A; Metzler M; Meyer LH; Meyer C; Harbott J; Marschalek R; Strehl S; Haas OA; Panzer-Grümayer R
    Blood; 2011 Mar; 117(9):2658-67. PubMed ID: 21224468
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Relapse of TEL-AML1--positive acute lymphoblastic leukemia in childhood: a matched-pair analysis.
    Seeger K; von Stackelberg A; Taube T; Buchwald D; Körner G; Suttorp M; Dörffel W; Tausch W; Henze G
    J Clin Oncol; 2001 Jul; 19(13):3188-93. PubMed ID: 11432885
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gene expression profiling reveals intrinsic differences between T-cell acute lymphoblastic leukemia and T-cell lymphoblastic lymphoma.
    Raetz EA; Perkins SL; Bhojwani D; Smock K; Philip M; Carroll WL; Min DJ
    Pediatr Blood Cancer; 2006 Aug; 47(2):130-40. PubMed ID: 16358311
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Validation by RQ-PCR and flow cytometry of alpha-defensin1-3 (DEFA1-3) overexpression in relapsed and refractory acute lymphoblastic leukemia.
    Te Kronnie G; Bicciato S; Franceschini L; Accordi B; Dellíorto MC; Rinaldi A; Pession A; Barisone E; Conter V; Locatelli F; Basso G
    Oncol Rep; 2006 Feb; 15(2):341-6. PubMed ID: 16391852
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Oligoclonality and new agent evaluation in acute lymphoblastic leukaemia.
    Gaynon PS; Sun W
    Br J Haematol; 2016 Jun; 173(6):950-7. PubMed ID: 27221005
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunogenotype changes prevail in relapses of young children with TEL-AML1-positive acute lymphoblastic leukemia and derive mainly from clonal selection.
    Panzer-Grümayer ER; Cazzaniga G; van der Velden VH; del Giudice L; Peham M; Mann G; Eckert C; Schrauder A; Germano G; Harbott J; Basso G; Biondi A; van Dongen JJ; Gadner H; Haas OA
    Clin Cancer Res; 2005 Nov; 11(21):7720-7. PubMed ID: 16278392
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Deep targeted sequencing in pediatric acute lymphoblastic leukemia unveils distinct mutational patterns between genetic subtypes and novel relapse-associated genes.
    Lindqvist CM; Lundmark A; Nordlund J; Freyhult E; Ekman D; Carlsson Almlöf J; Raine A; Övernäs E; Abrahamsson J; Frost BM; Grandér D; Heyman M; Palle J; Forestier E; Lönnerholm G; Berglund EC; Syvänen AC
    Oncotarget; 2016 Sep; 7(39):64071-64088. PubMed ID: 27590521
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Meta-analysis of gene expression in relapsed childhood B-acute lymphoblastic leukemia.
    Chow YP; Alias H; Jamal R
    BMC Cancer; 2017 Feb; 17(1):120. PubMed ID: 28183295
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of diagnostic and relapse flow cytometry phenotypes in childhood acute lymphoblastic leukemia: implications for residual disease detection: a report from the children's oncology group.
    Borowitz MJ; Pullen DJ; Winick N; Martin PL; Bowman WP; Camitta B
    Cytometry B Clin Cytom; 2005 Nov; 68(1):18-24. PubMed ID: 16184615
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Outcome of pediatric acute lymphoblastic leukemia with very late relapse: a retrospective analysis by the Tokyo Children's Cancer Study Group (TCCSG).
    Kato M; Manabe A; Saito AM; Koh K; Inukai T; Ogawa C; Goto H; Tsuchida M; Ohara A
    Int J Hematol; 2015 Jan; 101(1):52-7. PubMed ID: 25432437
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mutational dynamics of early and late relapsed childhood ALL: rapid clonal expansion and long-term dormancy.
    Spinella JF; Richer C; Cassart P; Ouimet M; Healy J; Sinnett D
    Blood Adv; 2018 Feb; 2(3):177-188. PubMed ID: 29365312
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Use of molecular techniques to confirm true re-emergence of the original clone and to track minimal residual disease in a case of late extramedullary relapse of childhood acute lymphoblastic leukemia.
    Valetto A; Anselmi G; Scuderi F; Lanciotti M; Chiesa V; Dini G
    Haematologica; 2000 Oct; 85(10):1102-3. PubMed ID: 11025609
    [No Abstract]   [Full Text] [Related]  

  • 36. Clonal origins of relapse in ETV6-RUNX1 acute lymphoblastic leukemia.
    van Delft FW; Horsley S; Colman S; Anderson K; Bateman C; Kempski H; Zuna J; Eckert C; Saha V; Kearney L; Ford A; Greaves M
    Blood; 2011 Jun; 117(23):6247-54. PubMed ID: 21482711
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Association of miRNAs expression profiles with prognosis and relapse in childhood acute lymphoblastic leukemia].
    Xu L; Liang YN; Luo XQ; Liu XD; Guo HX
    Zhonghua Xue Ye Xue Za Zhi; 2011 Mar; 32(3):178-81. PubMed ID: 21535956
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The gene expression signature of relapse in paediatric acute lymphoblastic leukaemia: implications for mechanisms of therapy failure.
    Beesley AH; Cummings AJ; Freitas JR; Hoffmann K; Firth MJ; Ford J; de Klerk NH; Kees UR
    Br J Haematol; 2005 Nov; 131(4):447-56. PubMed ID: 16281934
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Factors influencing survival after relapse from acute lymphoblastic leukemia: a Children's Oncology Group study.
    Nguyen K; Devidas M; Cheng SC; La M; Raetz EA; Carroll WL; Winick NJ; Hunger SP; Gaynon PS; Loh ML;
    Leukemia; 2008 Dec; 22(12):2142-50. PubMed ID: 18818707
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Morphologic, immunologic and cytogenetic studies in children with acute lymphoblastic leukemia at diagnosis and relapse: a Pediatric Oncology Group study.
    Abshire TC; Buchanan GR; Jackson JF; Shuster JJ; Brock B; Head D; Behm F; Crist WM; Link M; Borowitz M
    Leukemia; 1992 May; 6(5):357-62. PubMed ID: 1534389
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.